| 国产重组人肿瘤坏死因子受体-抗体融合蛋白在国内风湿性疾病治疗中的临床应用 |
| |
| 引用本文： | 田寿福,汪年松. 国产重组人肿瘤坏死因子受体-抗体融合蛋白在国内风湿性疾病治疗中的临床应用[J]. 世界临床药物, 2012, 33(6): 384-386 |
| |
| 作者姓名： | 田寿福 汪年松 |
| |
| 作者单位： | 1.上海交通大学附属第六人民医院肾内科,上海,200233;2.上海交通大学附属第六人民医院肾内科,上海,200233 |
| |
| 摘 要： | 生物制剂在国内风湿性疾病临床治疗中的应用越来越广泛,国产重组人肿瘤坏死因子受体-抗体融合蛋白近年在国内类风湿关节炎和强直性脊柱炎等风湿性疾病治疗中取得良好效果.本文综述其在风湿性疾病治疗中的国内临床应用.
|
| 关 键 词： | 益赛普 风湿性疾病 重组人肿瘤坏死因子受体-抗体融合蛋白 |
Domestic RhTNFR:Fc in the treatment of rheumatic diseases |
| |
| TIAN Shou-fu,WANG Nian-song. Domestic RhTNFR:Fc in the treatment of rheumatic diseases[J]. WORLD CLINICAL DRUGS, 2012, 33(6): 384-386 |
| |
| Authors: | TIAN Shou-fu WANG Nian-song |
| |
| Affiliation: | (Department of Nephrology,Shanghai No.6 People’s Hospital,Shanghai Jiaotong University,Shanghai 200233,China) |
| |
| Abstract: | With the development of modern biotechnology and the research on the pathogenesis of rheumatic diseases,biological agents have been more widely used in rheumatic diseases treatment.Domestic RhTNFR:Fc achieved good results in the treatment of rheumatoid arthritis and ankylosing spondylitis in recent years.This review describes the clinical application of domestic RhTNFR:Fc. |
| |
| Keywords: | etanercept rheumatic disease RhTNFR:Fc |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
